A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer

One of the major goals of precision oncology is to promote combination therapy to improve efficacy and reduce side effects of anti-cancer drugs based on their molecular mechanisms. In this study, we aimed to develop and validate new nanoformulations of docetaxel (DTX) and bortezomib (BTZ) for target...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Acta Pharmacol Sin
Main Authors: Wang, Xin-shuai, Kong, De-jiu, Lin, Tzu-yin, Li, Xiao-cen, Izumiya, Yoshihiro, Ding, Xue-zhen, Zhang, Li, Hu, Xiao-chen, Yang, Jun-qiang, Gao, She-gan, Lam, Kit S, Li, Yuan-pei
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2017
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520194/
https://ncbi.nlm.nih.gov/pubmed/28552907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2017.43
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker